154 related articles for article (PubMed ID: 35624071)
1. Survey on the Prescription Patterns of Pharmacological Agents in Individuals Who Have Committed Sexual Offenses During Forensic Outpatient Treatment in Germany: How Many Discontinue Testosterone Lowering Medication Under Parole?
Sauter J; Rettenberger M; Briken P; Turner D
J Sex Med; 2022 Jul; 19(7):1147-1155. PubMed ID: 35624071
[TBL] [Abstract][Full Text] [Related]
2. Prescription of testosterone-lowering medications for sex offender treatment in German forensic-psychiatric institutions.
Turner D; Basdekis-Jozsa R; Briken P
J Sex Med; 2013 Feb; 10(2):570-8. PubMed ID: 23088739
[TBL] [Abstract][Full Text] [Related]
3. Changing or stopping testosterone-lowering medication in men convicted of sexual offenses: clinical evaluation of the COSTLow-R Scale.
Wolba J; Tozdan S; Briken P; Freese R; Retz W; Turner D
J Sex Med; 2023 Mar; 20(4):549-558. PubMed ID: 36861326
[TBL] [Abstract][Full Text] [Related]
4. The impact of testosterone-lowering medication on recidivism in individuals convicted of sexual offenses.
Sauter J; Lingenti LM; Rettenberger M; Turner D; Briken P; Voß T
Dialogues Clin Neurosci; 2024; 26(1):28-37. PubMed ID: 38837043
[TBL] [Abstract][Full Text] [Related]
5. Testosterone-Lowering Medication and Its Association With Recidivism Risk in Individuals Convicted of Sexual Offenses.
Sauter J; Turner D; Briken P; Rettenberger M
Sex Abuse; 2021 Jun; 33(4):475-500. PubMed ID: 32167420
[TBL] [Abstract][Full Text] [Related]
6. Which factors influence the appropriateness of testosterone-lowering medications for sex offenders? A survey among clinicians from German forensic-psychiatric institutions.
Turner D; Basdekis-Jozsa R; Dekker A; Briken P
World J Biol Psychiatry; 2014 Aug; 15(6):472-8. PubMed ID: 24219802
[TBL] [Abstract][Full Text] [Related]
7. Antihormonal treatment of paraphilic patients in German forensic psychiatric clinics.
Czerny JP; Briken P; Berner W
Eur Psychiatry; 2002 Apr; 17(2):104-6. PubMed ID: 11973119
[TBL] [Abstract][Full Text] [Related]
8. Current Legal Situation for Patients with Paraphilic disorders and Implications of the ICD-11 for Paraphilic Disorders for Germany.
Briken P; Boetticher A; Krueger RB; Kismödi E; Reed GM
J Sex Med; 2019 Oct; 16(10):1615-1622. PubMed ID: 31447381
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological treatment of sexual offenders in German outpatient treatment centers.
Turner D; Gregório Hertz P; Sauter J; Briken P; Rettenberger M
Int Clin Psychopharmacol; 2018 Nov; 33(6):349-352. PubMed ID: 29738426
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological treatments for paraphilic patients and sexual offenders.
Briken P; Kafka MP
Curr Opin Psychiatry; 2007 Nov; 20(6):609-13. PubMed ID: 17921764
[TBL] [Abstract][Full Text] [Related]
11. Drug treatment of paraphilic and nonparaphilic sexual disorders.
Guay DR
Clin Ther; 2009 Jan; 31(1):1-31. PubMed ID: 19243704
[TBL] [Abstract][Full Text] [Related]
12. [Effectiveness of aftercare treatment after release from prison: A first evaluation of the forensic therapeutic outpatient clinic for serious violent and sexual offenders in Berlin].
Sauter J; Voss T; Dahle KP
Nervenarzt; 2015 May; 86(5):571-8. PubMed ID: 25476037
[TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapy of paraphilias with long-acting agonists of luteinizing hormone-releasing hormone: a systematic review.
Briken P; Hill A; Berner W
J Clin Psychiatry; 2003 Aug; 64(8):890-7. PubMed ID: 12927003
[TBL] [Abstract][Full Text] [Related]
14. Forensic Aftercare Facilities and Their Impact on the Releasability of Persons Who Committed Sexual Offenses: A Three Group Comparison.
Sauter J; Mauzaite A; Voß T; Vogel J
Int J Offender Ther Comp Criminol; 2024 Apr; ():306624X241246519. PubMed ID: 38678317
[TBL] [Abstract][Full Text] [Related]
15. Legal and Policy Implications in Mexico of Changes in ICD-11 Paraphilic Disorders.
Martínez-López JNI; Robles R; Fresán A; Montis IA; Kismödi E; Medina-Mora ME; Reed GM
J Sex Med; 2019 Oct; 16(10):1623-1637. PubMed ID: 31515198
[TBL] [Abstract][Full Text] [Related]
16. Sex hormones, neurotransmitters, and psychopharmacological treatments in men with paraphilic disorders.
Saleh FM; Berlin FS
J Child Sex Abus; 2003; 12(3-4):233-53. PubMed ID: 15308453
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Paraphilic Disorders in Sexual Offenders or Men With a Risk of Sexual Offending With Luteinizing Hormone-Releasing Hormone Agonists: An Updated Systematic Review.
Turner D; Briken P
J Sex Med; 2018 Jan; 15(1):77-93. PubMed ID: 29289377
[TBL] [Abstract][Full Text] [Related]
18. Differential pharmacological treatment of paraphilias and sex offenders.
Hill A; Briken P; Kraus C; Strohm K; Berner W
Int J Offender Ther Comp Criminol; 2003 Aug; 47(4):407-21. PubMed ID: 12971182
[TBL] [Abstract][Full Text] [Related]
19. Paraphilias, Sociodemographic and Forensic Profiles of Men Convicted of Sexual Offenses in Turkey.
Kok Kendirlioglu B; Ipekcioglu D; Havle N; Ilnem MC
Sex Abuse; 2024 Feb; 36(1):59-75. PubMed ID: 37635404
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological management of inappropriate sexual behaviours: a review of its evidence, rationale and scope in relation to men with intellectual disabilities.
Sajith SG; Morgan C; Clarke D
J Intellect Disabil Res; 2008 Dec; 52(12):1078-90. PubMed ID: 18557968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
